Metformine Sandoz (Metformin Hydrochloride)

Metformin Hydrochloride lowers blood sugar primarily by inhibiting hepatic gluconeogenesis through mitochondrial complex I inhibition and activation of AMP‑activated protein kinase. This enhances peripheral insulin sensitivity, increases glucose uptake in muscle and fat, and modestly reduces intestinal glucose absorption, collectively improving glycemic control without stimulating insulin secretion.

The dosage of Metformine Sandoz is individualized by the prescribing healthcare professional based on the patient’s renal function, glycemic targets, and tolerance. The prescriber determines the starting dose, titration schedule, and maximum daily amount, following clinical guidelines and product labeling.

Safety of metformin during pregnancy and lactation has not been definitively established. It may be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case carefully and discuss alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with sulfonylureas, metformin does not cause insulin‑induced hypoglycemia and is associated with weight neutrality or modest loss. Unlike insulin, it is oral and does not require injection. It is often used as first‑line therapy because of its efficacy, safety profile, and low cost relative to newer agents such as GLP‑1 receptor agonists.

Metformine Sandoz should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional. Adherence to the prescribed schedule is essential for optimal glycemic control.

The most critical adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Other serious concerns include severe hypoglycemia when combined with insulin or sulfonylureas, and vitamin B12 deficiency with long‑term use.

Metformine Sandoz is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in patients with severe hepatic disease. It should also be avoided in those with conditions predisposing to lactic acidosis.